Skip to content

A little signal. Less noise.

DISCOVER

Catalog Categories

CATEGORIES

Categories will appear when the source is connected.

More possibility. Less searching.

A considered collection of AI tools, trials, and opportunities.

RADAR / PostgreSQLConnection pending

ExploreCatalog

A little signal. Less noise.

Loading the catalog…

RADARGood tools open new possibilities.Explore thoughtfully. Create freely.

Skip to content

A little signal. Less noise.

DISCOVER

Catalog Categories

CATEGORIES

Categories will appear when the source is connected.

More possibility. Less searching.

A considered collection of AI tools, trials, and opportunities.

RADAR / PostgreSQLStorage available

ExploreOffer details

A little signal. Less noise.

Back to catalog

恒

恒瑞医药:氟唑帕利胶囊上市许可申请获 EMA 受理

Readhub

About this offer

恒瑞医药递交的氟唑帕利胶囊上市许可申请获欧洲药品管理局正式确认并受理,这是该公司第二款自主研发的创新药向欧盟递交上市申请。

Offer details

Provider: Readhub
Source: readhub-rss
Score: 57.39
Confidence: 54%

Source evidence

What RADAR observed and classified to build this opportunity. It is what the source published, not a verification that the offer is still active.

ReadhubObserved: Oct 8, 2026Source reliability: 60%
恒瑞医药:氟唑帕利胶囊上市许可申请获 EMA 受理. 恒瑞医药递交的氟唑帕利胶囊上市许可申请获欧洲药品管理局正式确认并受理,这是该公司第二款自主研发的创新药向欧盟递交上市申请。
Open source

恒瑞医药:氟唑帕利胶囊上市许可申请获 EMA 受理

Opens an external website. Availability and terms may change.

Real offers. Useful details.

The catalog shows persisted RADAR opportunities. Storage availability does not mean sources are verified or offers are active.

RADARGood tools open new possibilities.Explore thoughtfully. Create freely.